Hoffman Michael B

Hoffman Michael B is listed in filings as Chairman and CEO at Translational Development Acquisition Corp.. This profile follows SEC Form 4 activity through May 29, 2026, including purchase activity. Recent filings connect the profile to Translational Development Acquisition Corp. (TDAC) and Annovis Bio, Inc. (ANVS). The current snapshot covers public activity from Jun 2, 2025 to May 29, 2026. Reported amounts are shown as $614.0K to $70.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.